Shares of Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.14. Hemispherx BioPharma shares last traded at $0.12, with a volume of 798,651 shares.
Hemispherx BioPharma Price Performance
The company’s 50-day simple moving average is $0.18.
Hemispherx BioPharma Company Profile
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Read More
- Five stocks we like better than Hemispherx BioPharma
- What Makes a Stock a Good Dividend Stock?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What is a Dividend King?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
